Itrizole and blood lactate dehydrogenase increased Patient Reports February 13, 2012

Itrizole Side Effects Report #5502148-7
Itrizole side effect was reported by a Physician from JAPAN on Oct 25, 2007. Male patient, 65 years of age, weighting 112.4 lb, was diagnosed with prophylaxis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, chest x-ray abnormal, hyperbilirubinaemia. Itrizole dosage: unknown. During the same period patient was treated with MAXIPIME, CELLCEPT, PROGRAF, FRAGMIN. Patient died on 05/27/2007.

Itrizole Side Effects Report #5521042-9
Itrizole side effect was reported by a Physician from JAPAN on Nov 08, 2007. Male patient, 65 years of age, weighting 112.4 lb, was diagnosed with prophylaxis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, blood urea increased, chest x-ray abnormal, hyperbilirubinaemia. Itrizole dosage: unknown. During the same period patient was treated with PROGRAF, MAXIPIME, CELLCEPT, FRAGMIN. Patient died on 05/27/2007.

Itrizole Side Effects Report #5594428-4
Itrizole side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma , purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.

Itrizole Side Effects Report #5605650-2
Itrizole side effect was reported by a Physician from JAPAN on Jan 21, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma , purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.


Itrizole Side Effects Report #5804741-0
Itrizole side effect was reported by a Physician from JAPAN on July 01, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, neutrophil count decreased, platelet count decreased, purpura, pyrexia, respiratory disorder, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.

Itrizole Side Effects Report #6129851-2
Itrizole side effect was reported by a Pharmacist from JAPAN on Mar 16, 2009. Male patient, 18 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myoglobin blood increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #6137189-2
Itrizole side effect was reported by a Pharmacist from JAPAN on Mar 19, 2009. Male patient, 18 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myoglobin blood increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #5827185-4
Itrizole side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, weighting 121.3 lb, was diagnosed with febrile neutropenia, prophylaxis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood alkaline phosphatase increased, blood chloride increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium increased, blood urea increased, condition aggravated, gamma-glutamyltransferase increased. Itrizole dosage: unknown. During the same period patient was treated with MAXIPIME, NEUTROGIN, NOVANTRONE, MORPHINE ELIXIR, FAMOTIDINE. Patient was hospitalized. Patient died on 12/20/2007.

Itrizole Side Effects Report #5853542-6
Itrizole side effect was reported by a Physician from JAPAN on Aug 18, 2008. Male patient, weighting 121.3 lb, was diagnosed with febrile neutropenia, acute myeloid leukaemia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood chloride increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium increased, blood urea increased, gamma-glutamyltransferase increased, white blood cell count increased. Itrizole dosage: unknown. During the same period patient was treated with IDAMYCIN, MEROPEN, MAXIPIME, NEUTROGIN, NOVANTRONE. Patient was hospitalized. Patient died on 12/20/2007.


Itrizole Side Effects Report #5892447-1
Itrizole side effect was reported by a Physician from JAPAN on Sept 19, 2008. Male patient, weighting 121.3 lb, was diagnosed with febrile neutropenia, acute myeloid leukaemia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood chloride increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium increased, blood urea increased, gamma-glutamyltransferase increased, white blood cell count increased. Itrizole dosage: unknown. During the same period patient was treated with IDAMYCIN, MEROPEN, MAXIPIME, NEUTROGIN, NOVANTRONE. Patient was hospitalized. Patient died on 12/20/2007.

Itrizole Side Effects Report #5899473-7
Itrizole side effect was reported by a Physician from JAPAN on Sept 19, 2008. Female patient, weighting 81.57 lb, was diagnosed with febrile neutropenia, leukaemic infiltration pulmonary, acute myeloid leukaemia, cancer pain, angina pectoris, hypertension and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase increased, hypochloraemia, hypokalaemia, leukaemia, liver disorder, white blood cell count increased. Itrizole dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, DUROTEP PATCH, SIGMART, DIOVAN. Patient was hospitalized. Patient died on 12/24/2007.

Itrizole Side Effects Report #4543184-7
Itrizole side effect was reported by a Physician from on Dec 20, 2004. Male patient, 69 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bradycardia, gamma-glutamyltransferase increased, hepatic function abnormal, ileus, nausea . Itrizole dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, FAMOTIDINE, NIFEDIPINE, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.

Itrizole Side Effects Report #4791823-8
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.

Itrizole Side Effects Report #4791824-X
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.


Itrizole Side Effects Report #5767540-4
Itrizole side effect was reported by a Physician from JAPAN on June 05, 2008. Female patient, weighting 132.3 lb, was diagnosed with febrile neutropenia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, neutropenia, white blood cell count increased. Itrizole dosage: unknown. During the same period patient was treated with ALKERAN, MAXIPIME. Patient died on 05/09/2008.